Pparα modulation-based therapy in central nervous system diseases

Deokho Lee, Yohei Tomita, William Allen, Kazuo Tsubota, Kazuno Negishi, Toshihide Kurihara

研究成果: Review article査読

9 被引用数 (Scopus)


The burden of neurodegenerative diseases in the central nervous system (CNS) is increasing globally. There are various risk factors for the development and progression of CNS diseases, such as inflammatory responses and metabolic derangements. Thus, curing CNS diseases requires the modulation of damaging signaling pathways through a multitude of mechanisms. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors (PPARα, PPARβ/δ, and PPARγ), and they work as master sensors and modulators of cellular metabolism. In this regard, PPARs have recently been suggested as promising therapeutic targets for suppressing the development of CNS diseases and their progressions. While the therapeutic role of PPARγ modulation in CNS diseases has been well reviewed, the role of PPARα modulation in these diseases has not been comprehensively summarized. The current review focuses on the therapeutic roles of PPARα modulation in CNS diseases, including those affecting the brain, spinal cord, and eye, with recent advances. Our review will enable more comprehensive therapeutic approaches to modulate PPARα for the prevention of and protection from various CNS diseases.

出版ステータスPublished - 2021 11月

ASJC Scopus subject areas

  • 生態、進化、行動および分類学
  • 生化学、遺伝学、分子生物学一般
  • 宇宙惑星科学
  • 古生物学


「Pparα modulation-based therapy in central nervous system diseases」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。